Trials / Completed
CompletedNCT00888264
A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder
A 6 Month Observational Multicentric Prospective Study Observing the Use of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder, in the Course of a Major Depressive Episode
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 152 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this NIS is to obtain data on how AAPs are used in DSM-IV-TR Bipolar I and II Disorder, in the course of a major depressive episode. Both the parameters of use of AAPs and clinical evaluation will be recorded and potential differences that may exist due to epidemiological factors or comorbidities will be analyzed.
Conditions
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2009-04-27
- Last updated
- 2010-12-22
Locations
45 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00888264. Inclusion in this directory is not an endorsement.